Cargando…

Understanding sarcoma drug resistance one cell at a time

Detalles Bibliográficos
Autores principales:	Cherradi-Lamhamedi, Salah-Eddine, Truong, Danh, Ludwig, Joseph A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992582/ https://www.ncbi.nlm.nih.gov/pubmed/35582528 http://dx.doi.org/10.20517/cdr.2021.87

Ejemplares similares

Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer
por: Truong, Danh D., et al.
Publicado: (2022)

Dual Targeting of the Insulin-Like Growth Factor and Collateral Pathways in Cancer: Combating Drug Resistance
por: Ludwig, Joseph A., et al.
Publicado: (2011)

Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing
por: Truong, Danh D., et al.
Publicado: (2023)

Multi-site desmoplastic small round cell tumors are genetically related and immune-cold
por: Wu, Chia-Chin, et al.
Publicado: (2022)

The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
por: Lamhamedi-Cherradi, Salah-Eddine, et al.
Publicado: (2022)

Understanding racial diversities in Kaposi's sarcoma
por: Godbole, Sheela, et al.
Publicado: (2019)

Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients
por: Molina, Eric R., et al.
Publicado: (2022)

Efficacy of ONC201 in Desmoplastic Small Round Cell Tumor()
por: Hayes-Jordan, Andrea A., et al.
Publicado: (2018)

Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma
por: Lamhamedi-Cherradi, Salah-Eddine, et al.
Publicado: (2021)

Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor
por: Menegaz, Brian A., et al.
Publicado: (2017)

Drug repositioning in sarcomas and other rare tumors
por: Lee, Alex T.J., et al.
Publicado: (2016)

Leaving no one behind – understanding environmental inequality in Europe
por: Ganzleben, Catherine, et al.
Publicado: (2020)

Kaposi’s Sarcoma, a Gateway to Understanding Healthcare Disparities Present in the Racial Minority Communities of America
por: Anthony, Michelle, et al.
Publicado: (2023)

Advances in understanding the mechanism of action of adult vaccines
por: Cunningham, Anthony L., et al.
Publicado: (2023)

Diabetic Foot Ulcer Microbiome: One Small Step for Molecular Microbiology . . . One Giant Leap for Understanding Diabetic Foot Ulcers?
por: Lipsky, Benjamin A., et al.
Publicado: (2013)

One more step towards a deeper understanding of the mechanisms of allergen immunotherapy
por: Incorvaia, Cristoforo
Publicado: (2018)

Ringing the alarm bell: Time to scale up drug-resistant tuberculosis preventive treatment
por: Malik, Amyn A., et al.
Publicado: (2021)

Teasing Diabetes Apart, One Locus at a Time
por: Leslie, R. David, et al.
Publicado: (2018)

Crippling HIV one mutation at a time
por: Allen, Todd M., et al.
Publicado: (2008)

Rebuilding limbs, one cell at a time
por: Leigh, Nicholas D., et al.
Publicado: (2022)

Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm
por: Mannello, Ferdinando
Publicado: (2013)

IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
por: Amin, Hesham M., et al.
Publicado: (2020)

The evolving management of epithelioid sarcoma
por: Alves, Anneke, et al.
Publicado: (2021)

Applying a One Health lens to understanding the impact of climate and environmental change on healthcare-associated infections
por: Graham, Sabrina B., et al.
Publicado: (2023)

Exploring the onto-politics of cannabis: Shifting drug policies and understandings in Norway
por: Dahl, Silje Louise, et al.
Publicado: (2021)

Every Minute Counts—The Time Is Now to Understand Predictors of Stroke in HIV
por: Srinivasa, Suman, et al.
Publicado: (2019)

Deconstructing pheromone-mediated behavior one layer at a time
por: Sánchez-Andrade, Gabriela, et al.
Publicado: (2014)

Moving the Pendulum for Glioblastoma Treatment: One Injection at a Time
por: Wu, Xizi, et al.
Publicado: (2023)

An evolutionary framework for treating pediatric sarcomas
por: Reed, Damon R., et al.
Publicado: (2020)

Understanding drug-cytokine synergistic toxicity
por: Wolenski, F S, et al.
Publicado: (2015)

The yin yang of sunitinib: One drug, two doses, and multiple outcomes
por: Elgendy, Mohamed
Publicado: (2017)

Commentary: Destination zero stroke: Three steps, but one at a time
por: Tatoulis, James
Publicado: (2021)

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
por: Castelli, Chiara, et al.
Publicado: (2013)

Mass drug administration for malaria elimination: do we understand the settings well enough?
por: Hetzel, Manuel W., et al.
Publicado: (2018)

Antimicrobial Resistance (AMR) in the Food Chain: Trade, One Health and Codex
por: George, Anna
Publicado: (2019)

An Update on Kaposi’s Sarcoma: Epidemiology, Pathogenesis and Treatment
por: Curtiss, Paul, et al.
Publicado: (2016)

The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance
por: Vandenbroucke-Grauls, Christina M J E, et al.
Publicado: (2019)

Advances in telemedicine using personal mobile devices: One patient at a time
por: Wac, Katarzyna
Publicado: (2022)

Time to look beyond one-year mortality in critically ill hematological patients?
por: Moors, Ine, et al.
Publicado: (2014)

When one cell is enough
por: Ceredig, Rhodri
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v0mjjkv17rnjacpiicf3s4qt2d